Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Cognitive Dysfunction × Acetylcysteine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Hearing Loss, Sensorineural 1 Hearing Loss 1 Ear Diseases 1 Deafness 1 Cognitive Dysfunction 1 Chemotherapy-Related Cognitive Impairment 1

Interventions

Vitamin D 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04520139 2026-03-10

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

University of California, Irvine

Phase 1/2 Not yet recruiting

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡